A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects

NCT01815684 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics
Pharmacodynamics
Healthy Subjects
Safety

Interventions

DRUG: ASP3652
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.